Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance To Observe Safety And Efficacy Of BeneFIX In Patients With Hemophilia B

NCT00484185 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00484185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00484185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance To Observe Safety And Efficacy Of BeneFIX In Patients With Hemophilia B
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2012
Enrollment
183 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b